Rivian Automotive (RIVN) formally introduced its R2 mid-size electric SUV on Thursday. The electric vehicle maker said R2 deliveries will start this spring, beginning with the R2 Performance with ...

CEO Robert Scaringe highlighted that "2025 was a year focused on execution at Rivian as we laid the foundations for scaling our business" and underscored the R1S's market position, stating it was "the ...

QD-OLED Alienware monitor delivers 240Hz gaming performance with true blacks, 0.03ms response time, and exceptional color accuracy. Complete review inside. Alienware - Official website The gaming ...

The Alienware 16X starts at $1,549 and caps out at $2,699. There are two GPU versions, one with an RTX 5060 and the other with an RTX 5070. However, the RTX 5060 comes with an Intel Core Ultra 7 255HX ...

HyperX Cloud Alpha 2 Wireless is a gaming headset built for players who value endurance and comfort above everything else. Designed as a successor to the original Cloud Alpha Wireless, it pushes ...

Solid gaming performance. Really bright, 240-Hz display. Convenient ports in the back. Responsive touchpad. Battery life is decent. Keyboard and palm rests get warm. Cheaper gaming laptops perform ...

Gaming laptops are an interesting market, and there are a ton of great options to choose from. The Alienware 16X Aurora is just one of them, and it’s the smaller cousin to the Alienware 18 Area-51 I ...

Our expert, award-winning staff selects the products we cover and rigorously researches and tests our top picks. If you buy through our links, we may get a commission. Matt Elliott is a senior editor ...

The Alienware 16 Area-51 sets the stage for the Dell-owned brand's new flagship laptop design. It certainly provides some intrigue with its looks, is quite potent and it operates without too much ...

Loeb does a pretty good job with everything in the issue. The continuity wonk inside of me is kind of mad that continuity for an alternate universe isn’t being followed, but the rest of the story ...

The Food and Drug Administration (FDA) has extended the review period for the supplemental New Drug Application (sNDA) for mitapivat in the treatment of adults with non-transfusion-dependent (NTD) and ...